CAS: 2143467-62-1
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | BPK-29 REF: 3D-TKD46762CAS: 2143467-62-1 | Min. 95% | To inquire | Wed 27 Nov 24 |
 | BPK-29 REF: TM-T13586CAS: 2143467-62-1 | 98% | 904.00 €~2,329.00 € | Wed 04 Dec 24 |
BPK-29
CAS:2143467-62-1
BPK-29 is a covalent chemical compound that was developed by the Bioprobes Laboratory, LLC. It …
Formula:
C26H32ClN3O3
Purity:
Min. 95%
Molecular weight:
470 g/mol
Ref: 3D-TKD46762
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Wednesday 27 Nov 2024
BPK-29
CAS:2143467-62-1
BPK-29 disrupts NR0B1 binding and modifies C274, inhibiting growth in KEAP1-mutant cancers.
Formula:
C26H32ClN3O3
Purity:
98%
Color and Shape:
Solid
Molecular weight:
470
Ref: TM-T13586
| 25mg | 1,410.00 € | ||
| 50mg | 1,845.00 € | ||
| 100mg | 2,329.00 € |
Estimated delivery in United States, on Wednesday 4 Dec 2024
